Rankings
▼
Calendar
CLDX Q2 2023 Earnings — Celldex Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
CLDX
Celldex Therapeutics, Inc.
$2B
Q2 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$268,000
+64.4% YoY
Gross Profit
-$26M
-9695.5% margin
Operating Income
-$33M
-12389.9% margin
Net Income
-$31M
-11381.3% margin
EPS (Diluted)
$-0.65
QoQ Revenue Growth
-72.3%
Cash Flow
Operating Cash Flow
-$27M
Free Cash Flow
-$28M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$299M
Total Liabilities
$22M
Stockholders' Equity
$278M
Cash & Equivalents
$28M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$268,000
$163,000
+64.4%
Gross Profit
-$26M
-$21M
-26.3%
Operating Income
-$33M
-$36M
+8.8%
Net Income
-$31M
-$36M
+15.3%
Revenue Segments
Grant
$252,000
94%
Service
$16,000
6%
← FY 2023
All Quarters
Q3 2023 →